Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
AR positive
i
Other names:
AR, AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1, Androgen receptor
Associations
(26)
News
Trials
A2 | Sensitive
C2 | Sensitive
C3 | Sensitive
C4 | Sensitive
D | Sensitive
A2 | Resistant
C2 | Resistant
C3 | Resistant
C4 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Hormone Therapy
Other
Cyclin Dependent Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Epigenetics
Tyrosine Kinase Inhibitors
FGF
Cancel
Salivary Gland Cancer
Triple Negative Breast Cancer
Prostate Cancer
Breast Cancer
Estrogen Receptor Positive Breast Cancer
Ovarian Cancer
Urothelial Cancer
bicalutamide
A2
AR positive
|
Salivary Gland Cancer
|
bicalutamide
leuprolide acetate
A2
AR positive
|
Salivary Gland Cancer
|
leuprolide acetate
enzalutamide capsule
C2
AR positive
|
Triple Negative Breast Cancer
|
enzalutamide capsule
C3
AR positive
|
Ovarian Cancer
|
enzalutamide capsule
darolutamide
C2
AR positive
|
Salivary Gland Cancer
|
darolutamide
C2
AR positive
|
Triple Negative Breast Cancer
|
darolutamide
leuprolide acetate + bicalutamide
C3
AR positive
|
Salivary Gland Cancer
|
leuprolide acetate + bicalutamide
palbociclib
C3
AR positive
|
Triple Negative Breast Cancer
|
palbociclib
pembrolizumab
C3
AR positive
|
Triple Negative Breast Cancer
|
pembrolizumab
abiraterone acetate
C3
AR positive
|
Salivary Gland Cancer
|
abiraterone acetate
enobosarm
C2
AR positive
|
Estrogen Receptor Positive Breast Cancer
|
enobosarm
GT0918
D
AR positive
|
Prostate Cancer
|
GT0918
C2
AR positive
|
Breast Cancer
|
GT0918
C4
AR positive
|
Prostate Cancer
|
D
AR positive
|
Urothelial Cancer
|
erdafitinib + Debio 1347
D
AR positive
|
Prostate Cancer
|
erdafitinib + Debio 1347
C4
AR positive
|
Prostate Cancer
|
D
AR positive
|
Urothelial Cancer
|
FT-6876
D
AR positive
|
Breast Cancer
|
FT-6876
apalutamide
D
AR positive
|
Triple Negative Breast Cancer
|
apalutamide
abemaciclib
D
AR positive
|
Prostate Cancer
|
abemaciclib
HC-1119
D
AR positive
|
Triple Negative Breast Cancer
|
HC-1119
ceritinib
D
AR positive
|
Triple Negative Breast Cancer
|
ceritinib
enzalutamide capsule + ceritinib
D
AR positive
|
Triple Negative Breast Cancer
|
enzalutamide capsule + ceritinib
enzalutamide capsule + KRLS-017
D
AR positive
|
Triple Negative Breast Cancer
|
enzalutamide capsule + KRLS-017
VNLG-152R
D
AR positive
|
Triple Negative Breast Cancer
|
VNLG-152R
erdafitinib
D
AR positive
|
Prostate Cancer
|
erdafitinib
enzalutamide capsule + Debio 1347
D
AR positive
|
Prostate Cancer
|
enzalutamide capsule + Debio 1347
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
